The hemostasiologic research of thrombophilia markers was carried out during the prophylaxis of thrombotic complications at 49 pregnant women and women in birth having antiphosholipid syndrome during pregnancy and after the Cesarean section. 24 pregnant women of them received corticosteroid therapy during pregnancy and heparinoid “Pentosan polysulfate SP 54” in the postoperative period. The second group (25 pregnants, then women in birth) have got treatment with “Pentosan” before and after the operation. The risk of thrombotic complications development is proved to be lower in the group of patents having APHS, which received “Pentosan polysulfate SP 54” during pregnancy and postoperative period.
